397 related articles for article (PubMed ID: 17543568)
21. A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT).
Intra M; Gentilini O; Veronesi P; Ciocca M; Luini A; Lazzari R; Soteldo J; Farante G; Orecchia R; Veronesi U
Breast Cancer Res; 2005; 7(5):R828-32. PubMed ID: 16168129
[TBL] [Abstract][Full Text] [Related]
22. [Breast cancer after mantle field irradiation for Hodgkin's disease].
Katz A; Brenner B; Sulkes A; Luria H; Marshak G; Fenig E
Harefuah; 2000 May; 138(10):823-5, 911. PubMed ID: 10883245
[TBL] [Abstract][Full Text] [Related]
23. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
24. Association of thyroid carcinoma with malignant lymphoma.
Bakri KM; Shimaoka K; Gajera R; Getaz EP; Friedman M; Walsh D; Tsukada Y
Jpn J Clin Oncol; 1983 Dec; 13(4):645-55. PubMed ID: 6645082
[TBL] [Abstract][Full Text] [Related]
25. [Thoracic tumors after treatment for Hodgkin disease].
Watine O; Morel P; Bauters F; Ribet M
Ann Chir; 1995; 49(3):225-31. PubMed ID: 7793843
[TBL] [Abstract][Full Text] [Related]
26. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients.
Cutuli B; Dhermain F; Borel C; de Larochefordiere A; Graic Y; de Lafontan B; Dilhyudy JM; Mignotte H; Tessier E; Tortochaux J; N'Guyen T; Bey P; Le Mevel-Le Pourhiet A; Velten M; Arriagada R
Eur J Cancer; 1997 Dec; 33(14):2315-20. PubMed ID: 9616274
[TBL] [Abstract][Full Text] [Related]
28. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
[TBL] [Abstract][Full Text] [Related]
29. Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?
Chen J; Lee RJ; Tsodikov A; Smith L; Gaffney DK
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1474-9. PubMed ID: 15050326
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer.
Kumpulainen EJ; Hirvikoski PP; Johansson RT
Acta Oncol; 2008; 47(1):120-3. PubMed ID: 18097780
[TBL] [Abstract][Full Text] [Related]
31. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk following irradiation for Hodgkin's disease.
Clemons M; Loijens L; Goss P
Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
[TBL] [Abstract][Full Text] [Related]
33. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
34. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
[TBL] [Abstract][Full Text] [Related]
35. [Preliminary results of reproductive system function assessment in young men after Hodgkin's disease therapy].
Moryl-Bujakowska A; Balwierz W; Małek A; Sztefko K
Przegl Lek; 2010; 67(6):382-6. PubMed ID: 21344766
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.
Cutuli B; Borel C; Dhermain F; Magrini SM; Wasserman TH; Bogart JA; Provencio M; de Lafontan B; de la Rochefordiere A; Cellai E; Graic Y; Kerbrat P; Alzieu C; Teissier E; Dilhuydy JM; Mignotte H; Velten M
Radiother Oncol; 2001 Jun; 59(3):247-55. PubMed ID: 11369065
[TBL] [Abstract][Full Text] [Related]
37. Time interval to the development of breast carcinoma after treatment for Hodgkin disease.
Wendland MM; Tsodikov A; Glenn MJ; Gaffney DK
Cancer; 2004 Sep; 101(6):1275-82. PubMed ID: 15316904
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer in women following mantle irradiation for Hodgkin's disease.
Peters MH; Sonpal IM; Batra MK
Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
[TBL] [Abstract][Full Text] [Related]
39. Late effects after therapy of Hodgkin's disease: update 2003/04 on overwhelming post-splenectomy infections and secondary malignancies.
Schellong G; Riepenhausen M
Klin Padiatr; 2004; 216(6):364-9. PubMed ID: 15565552
[TBL] [Abstract][Full Text] [Related]
40. Local therapy for breast cancer in malignant lymphoma survivors.
Intra M; Mattar D; Sangalli C; Rotmensz N; Viale G; Galimberti V; Luini A; Veronesi P; Colleoni M; Zurrida S; Orecchia R; Veronesi U
Breast; 2011 Oct; 20 Suppl 3():S99-103. PubMed ID: 22015303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
